Pharmacoeconomic Impact of Use of the Probiotic Lactobacillus Reuteri DSM 17938 for Prevention of Necrotizing Enterocolitis in Extremely Low-Birth-Weight Infants

Research and Reports in Neonatology
doi 10.2147/rrn.s43272
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search